The most extensively studied compounds are exenatide (Byetta [Amylin Pharmaceuticals, San Diego, CA], which has been approved by the US Food and Drug Administration [FDA] for the treatment of type 2 diabetes), liraglutide (Victoza [Novo Nordisk, Princeton, NJ], which has been submitted to the FDA for approval), sitaglitptin (Januvia [Abbott Laboratories, Abbott Park, IL], which has been approved by the FDA for type 2 diabetes), and vildagliptin (Galvus [Novo Nordisk, Princeton, NJ], which has been submitted to FDA)
On average, patients may lose about 1 to 2 pounds per week, meaning it could take approximately 10 to 20 weeks to lose 20 pounds
If you feel your heart racing , contact your clinician for guidance
Emerging concerns include: Risks of micronutrient deficiencies caused by very low food intake